This limits its effectiveness for some users
If you're six weeks in with no scale movement, the medication may simply be doing exactly what it's designed to do at that stage
Type 2 diabetes Treatment summaries, BNF
Nayan Patel: We have this product ready
However, there are still challenges that need to be addressed, such as the optimization of properties, reliable characterization methods, safety evaluation, nanoparticles that might lead to unintended consequences like nano-pollution and cytotoxicity and regulatory aspects related to nanomedicines targeting skin cancer [176, 179]
Graycar JL, Miller DA, Arrick BA, Lyons RM, Moses HL, & Derynck R (1989) Human transforming growth factor-beta-3: recombinant expression, purification, and biologic activities in comparison with transforming growth factors beta 1 and beta 2